Harry’s guest is Dr. Shrujal Baxi, medical director of Flatiron Health. On the agenda: how technology can help create the real-world evidence needed to achieve better patient outcomes and accelerate research into new areas.
Harry asks Dr. Ron Alfa, vice president of discovery and product at Recursion Pharmaceuticals, what efficiencies could be achieved and what problems could be solved if data science were applied to drug discovery.
Harry’s guest is Guido Lanza, president and CEO of Numerate. They tackle the question: What if the introduction of Artificial Intelligence into drug discovery allowed us to create a true learning loop?
To listen to the podcast via iTunes click here
At MoneyBall Medicine, host Harry Glorikian talks with leaders in the healthcare and life sciences industry about the ongoing data-driven transformation of their industry. Click here for more.